search all topics discussed by SAGE since 1997 ( you may use single or double quotes to group terms ie "yellow fever" measles 'pertussis control' )
Report from the WHO Department of Immunization, Vaccines and Biologicals focused on: (i) the Global Vaccine Action Plan (GVAP) roll-out; (ii) the strengthening of routine immunization and efforts to integrate immunization and other child health interventions; and (iii) the changing epidemiology of measles.
Report from the GAVI Alliance: update on: (i) the processes and timelines for developing the next Vaccine Investment Strategy (for the period 2015–2020) beyond existing commitments, (ii) the preliminary Board discussions regarding GAVI’s potential role in supporting the GPEI, including supporting inactivated polio vaccine (IPV) introduction and potential innovative financing instruments for mobilizing resources, and (iii) the preparations for the next GAVI replenishment round in 2014.
Report from the Global Advisory Committee on Vaccine Safety (GACVS) : A report of the December 2012 GACVS meeting was presented.
Report from the Immunization Practice Advisory Committee (IPAC): A report of the April 2013 IPAC meeting was presented.
Dengue vaccines: epidemiology; review of the results of the Phase IIb trial of the lead vaccine candidate, a tetravalent live attenuated vaccine and other considerations.
Polio eradication: progress and challenges.
Yellow fever vaccination: A report was presented from the SAGE working group on yellow fever (YF) vaccines.
Non-specific effects of vaccines on mortality: established a working group to review data on non-specific effects and consider whether current evidence is sufficient to merit adjustments in policy recommendations, or may warrant further scientific investigation and if so, to outline a path towards obtaining unequivocal evidence that would inform future robust, evidence-based adjustments in immunization policies, if warranted.
Haemophilus influenza type b (Hib) immunization schedules.